about
Breaking the Meyer-Overton rule: predicted effects of varying stiffness and interfacial activity on the intrinsic potency of anesthetics.Phosphatidylethanolamine critically supports internalization of cell-penetrating protein C inhibitorThe genetic interactome of prohibitins: coordinated control of cardiolipin and phosphatidylethanolamine by conserved regulators in mitochondria.FMP30 is required for the maintenance of a normal cardiolipin level and mitochondrial morphology in the absence of mitochondrial phosphatidylethanolamine synthesis.Elo1p-dependent carboxy-terminal elongation of C14:1Delta(9) to C16:1Delta(11) fatty acids in Saccharomyces cerevisiae.MAS (1)H NMR Probes Freezing Point Depression of Water and Liquid-Gel Phase Transitions in LiposomesAntimicrobial peptide cWFW kills by combining lipid phase separation with autolysis.Elastic deformations in hexagonal phases studied by small-angle X-ray diffraction and simulations.Chemical shift tensor - the heart of NMR: Insights into biological aspects of proteinsTheory of lipid polymorphism: application to phosphatidylethanolamine and phosphatidylserineField theoretic study of bilayer membrane fusion. I. Hemifusion mechanism.Membrane restructuring by Bordetella pertussis adenylate cyclase toxin, a member of the RTX toxin family.Enhanced association of mutant triosephosphate isomerase to red cell membranes and to brain microtubulesLipid polymorphisms and membrane shapeLyotropic liquid crystal engineering moving beyond binary compositional space - ordered nanostructured amphiphile self-assembly materials by design.The ionization properties of cardiolipin and its variants in model bilayers.Membranes: a meeting point for lipids, proteins and therapiesLipid crystallization: from self-assembly to hierarchical and biological ordering.Thermosensing to adjust bacterial virulence in a fluctuating environment.Synthetic lethal interaction of the mitochondrial phosphatidylethanolamine and cardiolipin biosynthetic pathways in Saccharomyces cerevisiae.Interaction of LL-37 with model membrane systems of different complexity: influence of the lipid matrix.Roles of phosphatidylethanolamine and of its several biosynthetic pathways in Saccharomyces cerevisiae.Cytochrome P450 Organization and Function Are Modulated by Endoplasmic Reticulum Phospholipid Heterogeneity.Spotlight on Biomimetic Systems Based on Lyotropic Liquid Crystal.Lipid composition and the lateral pressure profile in bilayers.Solute modulation of conformational equilibria in intrinsic membrane proteins: apparent "cooperativity" without binding.Thermotropic phase behavior of monoglyceride-dicetylphosphate dispersions and interactions with proteins: a (2)H and (31)P NMR study.Effect of phospholipids and a transmembrane peptide on the stability of the cubic phase of monoolein: implication for protein crystallization from a cubic phase.Influenza A M2 protein conformation depends on choice of model membrane.Insertion of perilipin 3 into a glycero(phospho)lipid monolayer depends on lipid headgroup and acyl chain species.Dramatic destabilization of transmembrane helix interactions by features of natural membrane environments.Age-related changes in central nervous system phosphatidylserine decarboxylase activity.Reversible topological organization within a polytopic membrane protein is governed by a change in membrane phospholipid composition.Lipid nanoscaffolds in carbon nanotube arrays.Membrane-Active Properties of an Amphitropic Peptide from the CyaA Toxin Translocation Region.Phosphatidylethanolamine mediates insertion of the catalytic domain of leader peptidase in membranes.Pressure effects on a protein–lipid model membrane
P2860
Q24537455-12687732-20E5-4159-8F52-28F17EDD600EQ24676276-FF3F5DBF-8C6B-46B4-A6E7-9DAE39ED86A1Q27936543-2117E4B4-0E82-4EA2-9091-115CF3A2C1B9Q27937828-BBAB8213-105D-445A-ABE6-753474F4D5FBQ27938835-92E7FC62-6B98-408D-B10F-EED4FF5BBD94Q28393745-FA98B649-10AF-4F5B-9718-528617CCEBE0Q30841307-A905C9BA-FDFB-4662-99DF-9C6BE353B583Q33743096-C25CF234-884A-462D-A611-9F65562290C0Q34001644-CF1151AD-D3A8-4C9B-9809-3068F8A56472Q34172108-53C58E77-F9AA-4D9B-B0A3-8FB5BF3B8F95Q34187706-ABD31B8E-D6E8-4469-BEC7-CD46C091ECDBQ34324299-002B016F-C49F-47A0-810B-2D94A2F674D0Q34999755-620D7734-04FD-483E-9D83-7169FC467B4FQ35562197-D26A9BF9-BDA6-478E-92DB-611FE2439275Q36303724-3D55DB7F-6E9C-4DB8-9067-300C359ED836Q36980609-C593012C-7E8A-4A73-8E2A-1C53A9FDE75AQ37081783-EB3A773C-0CE4-451D-BD68-630B93AEAAE8Q38035193-7498703A-932B-4641-A13A-32DA1D650769Q38068486-61A6D55A-6D1F-4357-954B-6365D8C775D0Q38323374-43D395C7-8BF9-47A5-8A69-397BA6B99929Q38630326-2D5D13C4-0915-4A1B-BBAD-F3E0D55AC2C2Q38689610-86E0B5B4-7688-4518-AA2F-5E05DB7A3E78Q38846165-C297122F-39CE-42BE-BC4C-B951BBAE617EQ38921324-59FBEE20-7E1F-4FC7-A0C6-533B1CDDDFF0Q40142623-13E5A183-F1DC-4B3E-8BD2-CFCD0EE8C722Q40153112-EC081E57-782B-424F-83E3-B25CDEED9A01Q40201088-9D6262B9-748A-4705-8535-D944286D8315Q40233549-93584F0B-DE08-4E76-9867-44BE91756857Q41842286-9E26B06C-C95D-4CB0-B4D5-0C23B6DB76CDQ42406163-20CE6A32-5709-41D8-8658-FEA9A0113A0BQ42834959-AEB2851A-61B4-4BF8-B24C-84014BB7D2D3Q44187997-63042BCB-652E-4982-A193-92753263510DQ44606581-AA6042F8-32BB-4D45-80BF-2D79393BDA7FQ44650193-92DC0B8C-B480-46FF-ADA3-E8BE3F3ACF67Q47128421-62B0B959-41ED-49DA-AAA8-F78601A71EFFQ47763987-0E9ED937-4C58-4C63-9912-7FC4805D5093Q57904302-77C8DEB6-BD00-4724-B3AD-248B1FA51CD6
P2860
description
1997 nî lūn-bûn
@nan
1997 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Lipid polymorphism and biomembrane function.
@ast
Lipid polymorphism and biomembrane function.
@en
type
label
Lipid polymorphism and biomembrane function.
@ast
Lipid polymorphism and biomembrane function.
@en
prefLabel
Lipid polymorphism and biomembrane function.
@ast
Lipid polymorphism and biomembrane function.
@en
P1476
Lipid polymorphism and biomembrane function.
@en
P2093
de Kruijff B
P304
P356
10.1016/S1367-5931(97)80053-1
P577
1997-12-01T00:00:00Z